Global Bioenergies Statistics

Total Valuation

Global Bioenergies has a market cap or net worth of EUR 14.68 million. The enterprise value is 12.67 million.

Market Cap	14.68M
Enterprise Value	12.67M

Important Dates

The next estimated earnings date is Wednesday, December 11, 2024.

Earnings Date	Dec 11, 2024
Ex-Dividend Date	n/a

Share Statistics

Global Bioenergies has 18.13 million shares outstanding. The number of shares has increased by 11.98% in one year.

Current Share Class	n/a
Shares Outstanding	18.13M
Shares Change (YoY)	+11.98%
Shares Change (QoQ)	+1.55%
Owned by Insiders (%)	2.58%
Owned by Institutions (%)	3.94%
Float	15.21M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	30.75
PB Ratio	3.18
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.72
EV / Sales	26.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.70

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 1.23.

Current Ratio	2.06
Quick Ratio	1.67
Debt / Equity	1.23
Debt / EBITDA	n/a
Debt / FCF	-1.21
Interest Coverage	-52.50

Financial Efficiency

Return on equity (ROE) is -102.78% and return on invested capital (ROIC) is -41.40%.

Return on Equity (ROE)	-102.78%
Return on Assets (ROA)	-30.73%
Return on Capital (ROIC)	-41.40%
Revenue Per Employee	11,047
Profits Per Employee	-167,303
Employee Count	46
Asset Turnover	0.03
Inventory Turnover	0.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.18% in the last 52 weeks. The beta is 1.58, so Global Bioenergies's price volatility has been higher than the market average.

Beta (5Y)	1.58
52-Week Price Change	-62.18%
50-Day Moving Average	1.14
200-Day Moving Average	1.65
Relative Strength Index (RSI)	36.84
Average Volume (20 Days)	45,903

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Global Bioenergies had revenue of EUR 486,058 and -7.36 million in losses. Loss per share was -0.40.

Revenue	486,058
Gross Profit	-155,903
Operating Income	-8.67M
Pretax Income	-8.55M
Net Income	-7.36M
EBITDA	-5.74M
EBIT	-8.67M
Loss Per Share	-0.40

Full Income Statement

Balance Sheet

The company has 7.69 million in cash and 5.67 million in debt, giving a net cash position of 2.01 million or 0.11 per share.

Cash & Cash Equivalents	7.69M
Total Debt	5.67M
Net Cash	2.01M
Net Cash Per Share	0.11
Equity (Book Value)	4.62M
Book Value Per Share	0.26
Working Capital	6.19M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.05 million and capital expenditures -646,553, giving a free cash flow of -4.70 million.

Operating Cash Flow	-4.05M
Capital Expenditures	-646,553
Free Cash Flow	-4.70M
FCF Per Share	-0.26

Full Cash Flow Statement

Margins

Gross Margin	-32.07%
Operating Margin	-1,782.73%
Pretax Margin	-1,758.71%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-965.97%

Dividends & Yields

Global Bioenergies does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.98%
Shareholder Yield	-11.98%
Earnings Yield	-49.25%
FCF Yield	-31.98%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Global Bioenergies has an Altman Z-Score of 0.8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.8
Piotroski F-Score	n/a